Clinical Trial Update: NMDA Modulation in Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating NMDA receptor modulation as treatment for Major Depressive Disorder is currently recruiting at China Medical University Hosp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: China Medical University Hospital | Conditions: Major Depressive Disorder | Phase 2 | Status: RECRUITING